ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Senate Committee Directs NCI To Conduct Research To Eliminate Barriers To Enrollment On Clinical Trials.

July 6, 2007

NCAB Subcommittee Likes Organ Site Program, Except Smoking-Health

April 30, 1976

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

Funding Opportunities: HHMI Commits $300M To Support Early Career Scientists.

March 21, 2008

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

NCI Comprehensive Center List Omits Georgetown/Howard, Adds Arizona

June 1, 1990